Search results
COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says
Reuters· 14 hours agoVaccine makers should consider targeting one of the currently dominant JN.1 variants and...
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 3 days agoModerna said Friday that US drug regulators have approved its second product, a vaccine for...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 3 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 3 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
Benzinga via Yahoo Finance· 3 days agoOn Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 3 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
Moderna's mRNA bird flu vaccine trial is close to getting U.S. government funding
Quartz· 4 days agoThe U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R)...
Digital Journal· 15 hours agoAt a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 49% and the risk of distant metastasis ...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 3 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 3 days agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine,...